Initiation Draft, Day 22: Quiet Period, Banking Input, and Pay Structure

Quiet period - the label controls, not the allocation. A firm named as a co-manager on the prospectus cover is a manager/co-manager for purposes of FINRA Rule 2241(f), so the applicable post-IPO restriction is 40 days, not the 25 days that applies to syndicate members that participated but were not managers or co-managers. Day 22 is inside the 40-day window; publication waits until day 41. The junior analyst's 25-day reading is the most expensive error in the draft because it converts a scheduling problem into a rule violation with a supervisory record attached.

Banking input. Rule 2241(b) permits investment banking personnel to review a research report for factual accuracy only. They may not review, comment on, or approve the rating, price target, or conclusions. A jointly drafted bull-case paragraph is substantive input; delete it or have research rewrite it independently and document that the bankers saw only facts, not conclusions.

Vendor data. Under Regulation AC the analyst certifies that the views are genuinely held and the report is accurate. An unverified CAGR from a data feed is an unverified fact. Recompute from the 10-K and footnote the source of every non-original statistic.

Disclosures to add before filing. Co-manager role and receipt of compensation for investment banking services in the past 12 months; intent to seek such compensation in the next 3 months; rating distribution and the percentage of Buy ratings; the analyst certification; ownership disclosures.

It is not permissible as described. Rule 2241(d) prohibits tying analyst compensation to specific investment banking transactions or to contributions to a specific banking deal, and permits compensation based on the firm's overall investment banking revenue only if a committee of senior management - not the banking department - reviews and approves the arrangement.

A research P&L that credits research with a share of banking revenue is a direct conduit from deal revenue to the analyst's pay. Even if the research department runs the P&L, the linkage to individual mandates has to be severed: no named-deal credit, no scorecard item that rewards a specific transaction.

Fixes:

• Salary plus discretionary bonus set by senior management on research-specific metrics: estimate accuracy, report quality, client vote, not banking revenue.
• Written committee review of the compensation determination, retained as a record.
• Confirm the analyst is not supervised by investment banking personnel and that the firm's anti-retaliation policy is in writing - an unfavorable report must never cost an analyst pay or coverage.
• If overall banking revenue is used at all, the approval record is the defense; without it, the arrangement fails on its face.

The published report is the least interesting document in the file. The examiner will want:

• Communications with the subject company, including the plant visit: dates, attendees, what was discussed, and any notes or materials exchanged. These are retained for three years, the first two in an easily accessible place.
• Drafts and version history, including who edited what - particularly evidence that banking personnel saw only factual sections.
• The basis for the rating and price target: the model, the valuation work, and any internal emails showing the analyst's genuine view, because Reg AC certification is meaningless without them.
• The quiet-period calendar showing the IPO date, the firm's cover status, and the first permissible publication date - this is the easiest document to reconstruct badly.
• The compensation committee's review and the analyst's pre-clearance records for personal trades in covered names.
• The data vendor's raw output and the reconciliation to the 10-K, since the growth rate was never checked.

If the site-visit notes do not exist, the firm cannot show the report's basis, and the missing record is itself the finding.